Publications

[2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)]. Adler, Yehuda; Charron, Philippe; Imazio, Massimo; Badano, Luigi; Baron-Esquivias, Gonzalo; Bogaert, Jan; Brucato, Antonio; Gueret, Pascal; Klingel, Karin; Lionis, Christos; Maisch, Bernhard; Mayosi, Bongani; Pavie, Alain; Ristic, Arsen D.; Sabaté Tenas, Manel; Seferovic, Petar; Swedberg, Karl; Tomkowski, Witold; Società Europea di Cardiologia. Giornale Italiano Di Cardiologia (2006). 2015; 702-738: p.702-738. doi:10.1714/2088.22592
    Article
    Reply to "Letter to the editor: Comments on 'Value and determinants of the mean systemic filling pressure in critically ill patients'". Repessé, Xavier; Vieillard-Baron, Antoine. American Journal of Physiology. Heart and Circulatory Physiology. 2015; H1372-1373: p.H1372-1373. doi:10.1152/ajpheart.00686.2015
      Article
      Developmentally dynamic genome: Evidence of genetic influences on increases and decreases in conduct problems from early childhood to adolescence. Pingault, Jean-Baptiste; Rijsdijk, Frühling; Zheng, Yao; Plomin, Robert; Viding, Essi. Scientific Reports. 2015; 10053: p.10053. doi:10.1038/srep10053
        Article
        Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. Burdett, S.; Pignon, J. P.; Tierney, J.; Tribodet, H.; Stewart, L.; Le Pechoux, C.; Aupérin, A.; Le Chevalier, T.; Stephens, R. J.; Arriagada, R.; Higgins, J. P.; Johnson, D. H.; Van Meerbeeck, J.; Parmar, M. K.; Souhami, R. L.; Bergman, B.; Douillard, J. Y.; Dunant, A.; Endo, C.; Girling, D.; Kato, H.; Keller, S. M.; Kimura, H.; Knuuttila, A.; Kodama, K.; Komaki, R.; Kris, M. G.; Lad, T.; Mineo, T.; Piantadosi, S.; Rosell, R.; Scagliotti, G.; Seymour, L. K.; Shepherd, F. A.; Sylvester, R.; Tada, H.; Tanaka, F.; Torri, V.; Waller, D.; Liang, Y.. Cochrane Database Syst Rev. 2015; CD011430: p.CD011430. doi:10.1002/14651858.CD011430 10.1002/14651858.CD011430.

        Article
        Role and Effectiveness of Percutaneous Arterial Embolization in Hemodynamically Unstable Patients with Ruptured Splanchnic Artery Pseudoaneurysms. Dohan, Anthony; Eveno, Clarisse; Dautry, Raphael; Guerrache, Youcef; Camus, Marine; Boudiaf, Mourad; Gayat, Etienne; Le Dref, Olivier; Sirol, Marc; Soyer, Philippe. Cardiovascular and Interventional Radiology. 2015; 862-870: p.862-870. doi:10.1007/s00270-014-1002-2
          Article
          Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up. Levy, A.; Martelli, H.; Fayech, C.; Minard-Colin, V.; Dumas, I.; Gensse, M. C.; Le Deley, M. C.; Oberlin, O.; Haie-Meder, C.. Radiother Oncol. 2015; 206-12: p.206-12
          Article
          Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. Beresniak, Ariel; Caruba, Thibaut; Sabatier, Brigitte; Juillière, Yves; Dubourg, Olivier; Danchin, Nicolas. World Journal of Cardiology. 2015; 594-602: p.594-602. doi:10.4330/wjc.v7.i10.594
            Article
            Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection. Tsao, M. S.; Marguet, S.; Le Teuff, G.; Lantuejoul, S.; Shepherd, F. A.; Seymour, L.; Kratzke, R.; Graziano, S. L.; Popper, H. H.; Rosell, R.; Douillard, J. Y.; Le-Chevalier, T.; Pignon, J. P.; Soria, J. C.; Brambilla, E. M.. J Clin Oncol. 2015; 3439-46: p.3439-46. doi:10.1200/JCO.2014.58.8335 10.1200/JCO.2014.58.8335. Epub 2015 Apr 27.

            Article
            Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy. Blanchard, P.; Bakkour, M.; De Crevoisier, R.; Levy, A.; Baumert, H.; Patard, J. J.; Wibault, P.; Fizazi, K.; Bossi, A.. Urol Oncol. 2015; 108-e15-20: p.108-e15-20. doi:10.1016/j.urolonc.2014.07.020 10.1016/j.urolonc.2014.07.020. Epub 2014 Aug 28.

            Article
            Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva. Lancet Oncol. 2015; 1324-34: p.1324-34. doi:10.1016/S1470-2045(15)00188-6 10.1016/S1470-2045(15)00188-6. Epub 2015 Sep 3.

            Article